Chromocell Therapeutics Corp (CHRO)

Dec 20, 2024, 9:00 AM EST - 4 weeks ago

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine

Dec 18, 2024, 8:30 AM EST - 4 weeks ago

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

Nov 21, 2024, 9:49 AM EST - 2 months ago

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

Oct 29, 2024, 8:30 AM EDT - 2 months ago

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

Oct 24, 2024, 8:45 AM EDT - 3 months ago

Chromocell Announces Amendment to Stock Repurchase Plan

Sep 16, 2024, 8:35 AM EDT - 4 months ago

Chromocell to Participate in Life Sciences Investor Forum September 19th

Aug 7, 2024, 8:45 AM EDT - 5 months ago

Chromocell Announces Stock Repurchase Plan

Jul 15, 2024, 9:00 AM EDT - 6 months ago

Chromocell to Participate in the Virtual Investor Lunch Break Series

May 13, 2024, 9:00 AM EDT - 8 months ago

Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 2024

Apr 9, 2024, 8:30 AM EDT - 10 months ago

Chromocell Issues Letter to Stockholders from Chief Executive Officer

Mar 21, 2024, 8:30 AM EDT - 10 months ago

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

Mar 18, 2024, 10:00 AM EDT - 10 months ago

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

Mar 11, 2024, 9:00 AM EDT - 11 months ago

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

Feb 27, 2024, 8:00 AM EST - 11 months ago

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

Feb 21, 2024, 4:47 PM EST - 11 months ago

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

Feb 17, 2024, 7:45 AM EST - 11 months ago

U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week

AMDI MTRS RCAT UMAC WETH

Feb 16, 2024, 8:00 AM EST - 1 year ago

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

Oct 19, 2023, 5:31 PM EDT - 1 year ago

IPO Update: Chromocell Therapeutics Seeks $8.7 Million In Micro-IPO

Feb 2, 2023, 1:35 PM EST - 2 years ago

Chromocell Therapeutics Seeks IPO For Erythromelalgia Treatment

Jan 11, 2023, 6:00 AM EST - 2 years ago

Chromocell Therapeutics Files for IPO

Jan 11, 2023, 5:30 AM EST - 2 years ago

Chromocell Therapeutics IPO Registration Document (S-1)